FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study.
about
Second-line systemic therapy for metastatic colorectal cancer.Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab.Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis of More Than 20 000 Patients.Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis.Therapeutic approaches for patients with coexisting familial adenomatous polyposis and colorectal cancer.Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review.Rationale and design of the TRUSTY study: a randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic co
P2860
Q30238760-3BE5A576-2033-4849-8F1A-355FCB5EF155Q33439464-255A58B2-A474-4011-8A2E-C84136AE7A40Q38371293-2E8865A2-A20C-4DAA-BBE7-ABFBA51BA687Q39011428-87A8FB4E-A663-4D08-8FF5-087F8E679A1FQ39600464-1CBCC330-15D3-4088-BDB5-8504E7171D45Q50350183-5509E103-5EDE-4A85-B4FD-A3D355A6881BQ58773448-DE20E608-8E9D-491C-976E-5CE33E377AA8
P2860
FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
FOLFIRI plus bevacizumab as se ...... domized phase III EAGLE study.
@ast
FOLFIRI plus bevacizumab as se ...... domized phase III EAGLE study.
@en
type
label
FOLFIRI plus bevacizumab as se ...... domized phase III EAGLE study.
@ast
FOLFIRI plus bevacizumab as se ...... domized phase III EAGLE study.
@en
prefLabel
FOLFIRI plus bevacizumab as se ...... domized phase III EAGLE study.
@ast
FOLFIRI plus bevacizumab as se ...... domized phase III EAGLE study.
@en
P2093
P2860
P356
P1433
P1476
FOLFIRI plus bevacizumab as se ...... ndomized phase III EAGLE study
@en
P2093
H Tamagawa
J Sakamoto
M Nakamura
P2860
P304
P356
10.1093/ANNONC/MDV197
P50
P577
2015-04-23T00:00:00Z